Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-01

Clinical Trial Update: The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial update examining how phenytoin affects nevirapine pharmacokinetics and potential nevirapine resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)
  • Phenytoin (Phenytoin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: HIV-infection, Pregnancy | Phase 2 | Status: COMPLETED